α‐Synuclein in Parkinson's Disease: From Bench to Bedside
Medicinal Research Reviews · 2025-05 · 45 (3) · 909-946
DOI: 10.1002/med.22091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 20.12.2024. Verfasst von Gabriele Bellini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neurodegenerative Diseases, Unit of Neurology, Parkinson's Disease and Movement Disorders, Department of Clinical and Experimental Medicin…. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Translational Research, Biomedical. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
α‐Synuclein (α‐syn), a pathological hallmark of PD, is emerging as a bridging element at the crossroads between neuro/immune‐inflammatory responses and neurodegeneration in PD. Several evidence show that pathological α‐syn accumulates in neuronal and non‐neuronal cells (i.e., neurons, microglia, macrophages, skin cells, and intestinal cells) in central and peripheral tissues since the prodromal phase of the disease, contributing to brain pathology. Indeed, pathological α‐syn deposition can promote neurogenic/immune‐inflammatory responses that contribute to systemic and central neuroinflammation associated with PD. After providing an overview of the structure and functions of physiological α‐syn as well as its pathological forms, we review current studies about the role of neuronal and non‐neuronal α‐syn at the crossroads between neuroinflammation and neurodegeneration in PD. In addition, we provide an overview of the correlation between the accumulation of α‐syn in central and peripheral tissues and PD, related symptoms, and neuroinflammation. Special attention was paid to discussing whether targeting α‐syn can represent a suitable therapeutical approach for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neurodegenerative Diseases, Unit of Neurology, Parkinson's Disease and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, New York City, New York, USA.
- Unit of Histology and Embryology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Neurology, Nantes Université, CHU Nantes, INSERM, Nantes, France.
ORCID-Profile: Gabriele Bellini, Vanessa D'Antongiovanni, Carolina Pellegrini
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Bellini, G., D'Antongiovanni, V., Palermo, G., Antonioli, L., Fornai, M., Ceravolo, R., Bernardini, N., Derkinderen, P., & Pellegrini, C. (2025). α‐Synuclein in Parkinson's Disease: From Bench to Bedside. Medicinal Research Reviews, 45(3), 909-946. https://doi.org/10.1002/med.22091
Vancouver
Bellini G, D'Antongiovanni V, Palermo G, Antonioli L, Fornai M, Ceravolo R, et al. α‐Synuclein in Parkinson's Disease: From Bench to Bedside. Medicinal Research Reviews. 2025;45(3):909-946. doi:10.1002/med.22091
BibTeX
@article{Bellini2025,
author = {Bellini, Gabriele and D'Antongiovanni, Vanessa and Palermo, Giovanni and Antonioli, Luca and Fornai, Matteo and Ceravolo, Roberto and Bernardini, Nunzia and Derkinderen, Pascal and Pellegrini, Carolina},
title = {α‐Synuclein in Parkinson's Disease: From Bench to Bedside},
journal = {Medicinal Research Reviews},
year = {2025},
volume = {45},
number = {3},
pages = {909--946},
doi = {10.1002/med.22091}
}
EUVIMED